Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1364, 2002-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Access to resources
Recommend
Lowering of LDL-cholesterol may increase risk of cancer
Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. :
More aggressive targeting of LDL-cholesterol warranted
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :
Intensive LDL-cholesterol lowering may be beneficial after MI
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
ACE inhibitors preferable in hypertension?
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :